Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Surgiform is a private U.S. medical device company focused on aesthetic, plastic, cosmetic, reconstructive, and dermatologic surgery. The company develops, manufactures, and distributes facial implants and related surgical products, including silicone implants, ePTFE implants, carvable implant materials, PTFE sutures, nasal splints, smoke evacuation devices, and scar treatment products. Its PureForm ePTFE implant line uses CTI Technology to promote tissue ingrowth and improve implant anchoring. Surgiform also manufactures products through Surgical Technology Laboratories and operates as an FDA-registered, ISO 13485-certified medical device establishment. The business appears centered on commercial-stage surgical products rather than a drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surgiform Technologies.